Stress-Reducing Interventions in HIV+ Patients: Pilot
PEACH
Pilot Intervention for PTSD, Nonadherence, and HIV Risk
2 other identifiers
interventional
70
1 country
2
Brief Summary
The primary aim of this project is to examine the efficacy of prolonged exposure (PE) therapy at reducing HIV-related PTSD symptoms, increasing adherence to antiretroviral medication regimens, and increasing health-related quality of life (QOL) in HIV+ patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2005
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2005
CompletedFirst Submitted
Initial submission to the registry
January 11, 2008
CompletedFirst Posted
Study publicly available on registry
January 24, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedMarch 5, 2009
March 1, 2009
3.8 years
January 11, 2008
March 4, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PTSD symptoms
pre- & post-intervention, 3-month post, & 6-month post
Secondary Outcomes (2)
Adherence to HIV medications
pre- & post-intervention, 3-month post, & 6-month post
Health-related Quality of Life
pre- & post-intervention, 3-month post, & 6-month post
Study Arms (2)
1
EXPERIMENTALProlonged Exposure Therapy.
2
NO INTERVENTIONWeekly monitoring/Waitlist Control Group.
Interventions
Participants will meet with a therapist twice a week for 5 weeks to complete the therapy. If the therapist and participant feel more sessions are needed, an additional 8 sessions will be provided.
Eligibility Criteria
You may qualify if:
- Must be HIV+
- Must meet PTSD diagnostic criteria
- Must be taking HIV medications
- Must be able to read and write in English
You may not qualify if:
- Current or previous diagnosis of schizophrenia, any current diagnosis with psychotic features, or current suicidal ideation
- Being in a current abusive relationship or ongoing intimate relationship with one's assailant
- Mental retardation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kent State Universitylead
- National Institute of Mental Health (NIMH)collaborator
- Summa Health Systemcollaborator
Study Sites (2)
Violet's Cupboard
Akron, Ohio, 44310, United States
AIDS Taskforce of Greater Cleveland
Cleveland, Ohio, 44115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Douglas L Delahanty, PhD
Kent State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 11, 2008
First Posted
January 24, 2008
Study Start
April 1, 2005
Primary Completion
February 1, 2009
Study Completion
February 1, 2010
Last Updated
March 5, 2009
Record last verified: 2009-03